Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

导出 LinkOut

翻译打印收藏纠错

作者： Sven E,Pålhagen ^[1] ; Olof,Sydow ^[2] ; Anders,Johansson ^[3] ; Dag,Nyholm ^[3] ; Bjorn,Holmberg ^[4] ; Hakan,Widner ^[5] ; Nil,Dizdar ^[6] ; Jan,Linder ^[7] ; Tove,Hauge ^[8] ; Rasmus,Jansson ^[9] ; Lars,Bergmann ^[10] ; Susanna,Kjellander ^[11] ; Thomas S,Marshall ^[10]

作者单位： Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. Electronic address: sven.palhagen@karolinska.se. ^[1] Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. ^[2] Department of Neuroscience, Neurology, Uppsala University, Sweden. ^[3] Department of Clinical Neuroscience, Sahlgrenska University Hospital, Gothenburg, Sweden. ^[4] Department of Neurology, Skane University Hospital, Lund, Sweden. ^[5] Department of Neurology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. ^[6] Department of Neurology, Neurocentre Norrlands University Hospital, Umeå, Sweden. ^[7] Department of Neurology, Molde Hospital HNR, Molde, Norway. ^[8] Department of Geriatric Medicine and Rehabilitation, Sundsvall Hospital, Sundsvall, Sweden. ^[9] AbbVie Inc., USA. ^[10] AbbVie AB, Sweden. ^[11]

关键词 Cost Infusion LCIG Levodopa Parkinson’s disease

主题词老年人(Aged);抗震颤麻痹药(Antiparkinson Agents);卡比多巴(Carbidopa);队列研究(Cohort Studies);复方合剂(Drug Combinations);女(雌)性(Female);凝胶类(Gels);卫生保健费用(Health Care Costs);人类(Humans);肠(Intestines);左旋多巴(Levodopa);男(雄)性(Male);中年人(Middle Aged);帕金森病(Parkinson Disease);疾病严重程度指数(Severity of Illness Index);统计学, 非参数(Statistics, Nonparametric)

DOI 10.1016/j.parkreldis.2016.06.002

PMID 27318707

发布时间 2022-03-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

Parkinsonism & related disorders

2016年29卷

17-23页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

Parkinsonism & related disorders

相似文献

Parkinsonism & related disorders

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.

Parkinsonism & related disorders

相似文献

Parkinsonism & related disorders

相关期刊

检索历史清除